Research Area: Cardiovascular.

Description

This group comprises physicians and econometrists of the Girona and Barcelona Health Regions with an interest in the study of the measurement of blood pressure, subclinical vascular disease associated with hypertension and the dynamic behaviour of cardiovascular risk factors. They collaborate with other investigators and networks within the IDIAP and other research bodies. The main objective of the group is to contribute information on 3 aspects of the role of blood pressure self-measurement (BPSM) with regard to the diagnosis of hypertension: 1.- Cut-off points of normality for the diagnosis of isolated clinical hypertension in relation to intermediate (evolution of subclinical vascular disease) and final variables (cardiovascular and renal morbidity and mortality ); 2.- Criteria for the diagnosis of isolated clinical hypertension or white coat hypertension; 3.- Optimal protocol for BPSM. The relationship between hypertension and subclinical vascular disease is concomitantly analysed. The research areas of this group are as follows: 1. Description of the normality cut-off points, the optimal protocol for measurement and diagnostic and prognostic value of BPSM; 2. Clinical validation of an automated screening of retinal microvasculature; 3. Assessment of the dynamic behaviour of metabolic syndrome and its components and cardiovascular morbidity and mortality; 4. Validation of specific cardiovascular risk tables for patients with Type 2 Diabetes.

Research Lines

Optimization of subclinical vascular disease in the diagnosis and monitoring of patients with HTA. Measurement of blood pressure outside the GP surgery. Metabolic syndrome and cardiovascular risk.

Members

Projects

Group projects

PI: Cerezo Goyeneche, Carlos. Ensayo híbrido de evaluación de una intervención compleja multiriesgo para promover conductas saludables en personas de 45-75 años atendidas en Atención Primaria: estudio EIRA3. Subproyecto Girona. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018

PI: Coll de Tuero, Gabriel. Comportamiento dinámico del síndrome metabólico y elaboración de una ecuación para predecir el riesgo cardiovascular en los pacientes con Diabetes tipo 2 de una cohorte retrospectiva obtenida a partir de una base de datos clínico administrativa. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018

PI: Benítez Camps, Mència. Evaluación de la relación entre paracetamol efervescente y presión arterial. Ensayo clínico. Funding: Reunions i Ciència, S.L. Duration: 2016

Publications

Group Publications:

Barceló MA, Coll-Negre M, Coll-de-Tuero G, Saez M. Effects of the Financial Crisis on Psychotropic Drug Consumption in a Cohort from a Semi-Urban Region in Catalonia, Spain. PloS one. 2016; 11(2):e0148594. doi:10.1371/journal.pone.0148594. pii:PONE-D-15-43821. PMID:26872210. FI: 3,057.

Paz MA, de-La-Sierra A, Sáez M, Barceló MA, Rodríguez JJ, Castro S, Lagarón C, Garrido JM, Vera P, Coll-de-Tuero G. Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement. Medicine. 2016 Jul; 95(30):e4071. doi:10.1097/MD.0000000000004071. PMID:27472680. FI: 2,133.

Rodríguez-Poncelas A, Mundet-Tudurí X, Miravet-Jiménez S, Casellas A, Barrot-De la Puente JF, Franch-Nadal J, Coll-de Tuero G. Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes. PLoS One. 2016 Feb 17;11(2):e0149448. doi: 10.1371/journal.pone.0149448. eCollection 2016. PubMed PMID: 26886129; PubMed Central PMCID: PMC4757564. FI: 3,057.

Ruiz-Tamayo I, Franch-Nadal J, Mata-Cases M, Mauricio D, Cos X, Rodriguez-Poncelas A, Barrot J, Coll-de-Tuero G, Mundet-Tudurí X. Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications? J Diabetes Res. 2016;2016:7502489. doi:10.1155/2016/7502489. Epub 2016 Jan 6. PubMed PMID: 26881258; PubMed Central PMCID: PMC4736814. FI: 2,431.

Sicras-Mainar A, Navarro-Artieda R, Ruiz-Torrejón A, Saez M, Coll-de Tuero G, Sánchez L. A retrospective, observational and multicentre study on patients with hyperactive bladder on treatment with mirabegron and oxybutinine under usual clinical practice conditions. Semergen. 2016 Jun; doi:10.1016/j.semerg.2016.05.006. Epub 2016 Zer 28. PMID:27371430.

Sicras-Mainar A, Navarro-Artieda R, Ruiz-Torrejón A, Sáez-Zafra M, Coll-de Tuero G. Persistence and concomitant medication in patients with overactive bladder treated with antimuscarinic agents in primary care. An observational baseline study. Actas urologicas espanolas. 2016 Mar; 40(2):96-101. doi:10.1016/j.acuro.2015.09.004. Epub 2015 Nov 6. PMID:26556482. FI: 0,667.

The group participates in the following publications:

Azagra R, Zwart M, Aguyé A, Martín-Sánchez JC, Casado E, Díaz-Herrera MA, Moriña D, Cooper C, Díez-Pérez A, Dennison EM; GROIMAP and FROCAT Study Group. Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool? Maturitas. 2016 Jan;83:65-71. doi: 10.1016/j.maturitas.2015.10.002. Epub 2015 Oct 21. PubMed PMID: 26546077 FI: 3,120.

Indicators